DexCom, Inc. (DXCM) Stock Price Today
Aura AI Summary
Key Stats
- $27.49BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $89.53FIFTY_TWO_WEEK_HIGH
- $54.84FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $26.46BENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track DexCom, Inc. (DXCM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, DexCom, Inc. has traded between a low of $54.84 and a high of $89.53, highlighting its annual price range. Buy and sell DexCom, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Most Recent News
Taiwan Freedom Project launches series to highlight Taiwan's geopolitical importance and counter CCP narratives.
The Taiwan Freedom Project has released a special 32-page section in The Washington Times titled "Why Taiwan Matters, Now More Than Ever," emphasizing Taiwan's critical geopolitical role and the threats it faces from China. The publication features b...

Alvotech's Celtic Lux Holdings pledges over 95 million shares and warrants in a June 26 transaction.
Alvotech announced that Celtic Lux Holdings S.a. r.l., formerly Alvogen Lux Holdings, pledged 88,940,619 shares and 7,007,321 Swedish warrants equivalent to shares on June 26. This transaction was reported to Luxembourg's financial regulator CSSF. Th...

Class action filed against Insulet over alleged product safety and disclosure issues, stock drops follow.
A class action lawsuit has been filed against Insulet Corporation by investors who bought shares between February 2025 and May 2026. The suit alleges Insulet misled investors by failing to disclose defects in its manufacturing controls that posed saf...
